The interaction between apolipoprotein serum amyloid A and high-density lipoprotein

Biochemical and Biophysical Research Communications

Volumn 317, Issue 1, 2004, Pages 157-161

  Wang, Limin ^a,b   Colón, Wilfredo ^a  

^a Research Rensselaer Polytechnic Institute   (United States)

^b WADSWORTH CENTER   (United States)

Author keywords

Acute phase; Atherosclerosis; Cholesterol; HDL; Inflammation; SAA

Indexed keywords

APOLIPOPROTEIN A1; GLUTARALDEHYDE; HIGH DENSITY LIPOPROTEIN; SERUM AMYLOID A;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CROSS LINKING; MOUSE; MOUSE STRAIN; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN LIPID INTERACTION; PROTEIN PROTEIN INTERACTION; TEMPERATURE SENSITIVITY; THERMOSTABILITY;

AMINO ACID SEQUENCE; ANIMALS; CHROMATOGRAPHY, LIQUID; CROSS-LINKING REAGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GLUTARAL; LIPOPROTEINS, HDL; MASS SPECTROMETRY; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SERUM AMYLOID A PROTEIN;

MURINAE;

EID: 1642545190     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.03.027     Document Type: Article

References (20)

1. Brouillette C.G., Anantharamaiah G.M. Structural models of human apolipoprotein A-I. Biochim. Biophys. Acta. 1256:1995;103-129.
2. Nofer J.R., Kehrel B., Fobker M., Levkau B., Assmann G., Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis. 161:2002;1-16.
3. Schultz J.R., Verstuyft J.G., Gong E.L., Nichols A.V., Rubin E.M. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature. 365:1993;762-764.
4. Warden C.H., Hedrick C.C., Qiao J.-H., Castellani L.W., Lusis A.J. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. Science. 261:1993;469-472.
5. McAdam K.P.W.J., Sipe J.D. Murine model for human secondary amyloidosis: genetic variability of the acute-phase serum protein SAA response to endotoxins and casein. J. Exp. Med. 144:1976;1121-1127.
6. Clifton P.M., Mackinnon A.M., Barter P.J. Effects of serum amyloid A protein (SAA) on composition, size, and density of high density lipoproteins in subjects with myocardial infarction. J. Lipid Res. 26:1985;1389-1398.
7. Wang L., Lashuel H.A., Walz T., Colón W. Murine apolipoprotein serum amyloid A in solution forms a hexamer containing a central channel. Proc. Natl. Acad. Sci. USA. 99:2002;15947-15952.
8. Benditt E.P., Eriksen N. Amyloid protein SAA is associated with high density lipoprotein from human serum. Proc. Natl. Acad. Sci. USA. 74:1977;4025-4028.
9. Liang J.S., Schreiber B.M., Salmona M., Phillip G., Gonnerman W.A., de Beer F.C., Sipe J.D. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J. Lipid Res. 37:1996;2109-2116.
10. Patel H., Bramall J., Warters H., De Beers M.C., Woo P. Expression of recombinant human serum amyloid A in mammalian cells and demonstration of the region necessary for high-density lipoprotein binding and amyloid fibril formation by site-directed mutagenesis. Biochem. J. 318:1996;1041-1049.
11. Liang J., Elliott-Bryant R., Hajri T., Sipe J.D., Cathcart E.S. A unique amyloidogenic apolipoprotein serum amyloid A (apoSAA) isoform expressed by the amyloid resistant CE/J mouse strain exhibits higher affinity for macrophages than apoSAA1 and apoSAA2 expressed by amyloid susceptible CBA/J mice. Biochim. Biophys. Acta. 1394:1998;121-126.
12. Yamada T., Kluve-Beckerman B., Liepnieks J.J., Benson M.D. Fibril formation from recombinant human serum amyloid A. Biochim. Biophys. Acta. 1226:1994;323-329.
13. von Eckardstein A., Funke H., Walter M., Altland K., Bennighoven A., Assmann G. Structural analysis of human apolipoprotein A-I variants. Amino acid substitutions are nonrandomly distributed throughout the apolipoprotein A-I primary structure. J. Biol. Chem. 265:1990;8610-8617.
14. Craig W.S. Determination of quaternary structure of an active enzyme using chemical cross-linking with glutaraldehyde. Methods Enzymol. 156:1988;333-345.
15. Benditt E.P., Hoffman J.S., Eriksen N. SAA, an apoprotein of HDL: its structure and function. Ann. N. Y. Acad. Sci. 389:1982;183-189.
16. Borhani D.W., Rogers D.P., Engler J.A., Brouillette C.G. Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation. Proc. Natl. Acad. Sci. USA. 94:1997;12291-12296.
17. Ross R. Atherosclerosis - an inflammatory disease. New. Engl. J. Med. 340:1999;115-126.
18. von Eckardstein A., Nofer J.-R., Assmann G. HDL and atherosclerosis: role of cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 21:2001;13-27.
19. Urieli-Shoval S., Linke R.P., Matzner Y. Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states. Curr. Opin. Hematol. 7:2000;64-69.
20. Gillmore J.D., Lovat L.B., Persey M.R., Pepys M.B., Hawkins P.N. Amyloid load and clinical outcome in AA amyloidosis in relation to circulating concentration of serum amyloid A protein. Lancet. 358:2001;24-29.